NHS whole-gene screening helps tailor cancer care
How cutting-edge cancer genomics is now being used in mainstream cancer care.
Similar Posts
Sustainability in Sports: Reducing the Environmental Footprint of Athletic Events
In a world increasingly attuned to the imperatives of environmental conservation, the sports industry is stepping up to the plate, championing sustainability initiatives that aim to reduce the ecological footprint of athletic events. From local community fields to grandiose global spectacles, the realm of sports is undergoing a green transformation, embracing practices that ensure the…
7 Early Signs Of Arthritis You Should Never Ignore
In the United States, arthritis is a leading cause of work disability, affecting over 53.2 million people, according to the Centers for Disease Control and Prevention. It can happen for a number of reasons to adults at any age ― and the pain can be debilitating. The most common form of arthritis is osteoarthritis, but…
Mary Lou Retton Faces Long Recovery After Pneumonia Scare
Olympic gymnastics great Mary Lou Retton said she faces a long battle recuperating at home from a rare form of pneumonia in which doctors weren’t sure whether she would survive. In an interview that aired Monday on NBC’s “Today” show, Retton said while wearing a breathing tube pumping oxygen through her nose that she was…
MoonLake Immunotherapeutics explores sale | Reuters News Agency
Business & FinanceDealsHealth 14 July 2023, 5:43 pm 1 minute MoonLake Immunotherapeutics (MLTX.O), a developer of an antibody-derived treatment for inflammatory skin conditions, is working with an investment bank and having early-stage conversations with drugmakers interested in a potential acquisition. Market Impact MoonLake’s shares ended trading up 8.4% at $54.27 on the news on Friday,…
Obesity and Alzheimer’s drugs pack one-two punch to power Eli Lilly higher in 2024
Investor optimism for Eli Lilly ‘s diabetes and obesity treatments in 2023 lifted the stock to its seventh annual gain in a row. In the new year, it should be the same old story. Shares of Eli Lilly have taken a breather over the past three months, as investors book profits in the top performer…
